TY - JOUR T1 - A Highly Sensitive Fluorescent Microplate Method for the Determination of UDP-Glucuronosyl Transferase Activity in Tissues and Placental Cell Lines JF - Drug Metabolism and Disposition JO - Drug Metab Dispos SP - 1184 LP - 1186 VL - 28 IS - 10 AU - Abby C. Collier AU - Malcolm D. Tingle AU - Jeffrey A. Keelan AU - James W. Paxton AU - Murray D. Mitchell Y1 - 2000/10/01 UR - http://dmd.aspetjournals.org/content/28/10/1184.abstract N2 - The fluorescent compound 4-methylumbelliferone (4MU) can be used to detect uridine diphosphate glucuronosyl transferase activity by observing the fall in fluorescence as the compound is converted to 4-methylumbelliferone glucuronide. A microplate assay has been developed that has improved sensitivity and is faster and cheaper than the historical extraction method. Activity is detectable with approximately 10% of the protein required in the extraction method. Absence of extraction and cleanup procedures and the ability to observe reaction rate directly are also of great advantage to the researcher. Michaelis-Menten kinetic data from one healthy female human liver is presented. The extraction method yielded a meanVmax of 19.9 nmol/min/mg of protein and a mean Km of 652.5 μM on 1 day [n = 6, coefficients of variation (CV) 15 and 24%, respectively]. For the microplate method on 1 day, the meanVmax was 36.21 ± 1.3 nmol/min/mg of protein (CV = 3.7%), significantly (P < .0001) higher than for the extraction method. The meanKm, 175.4 ± 24.2 μM (CV = 14.5%), was significantly lower (P < .0001) than observed in the extraction method. The assay was performed in replicates of six over 6 days; average intra- and interassay coefficients of variation were 9 and 22% forVmax and 8 and 35% forKm, respectively, for the microplate method. The microplate method has also detected activity in the placental trophoblast-derived cell lines JEG-3, JAr, and BeWo (5.5, 4.1, and 2.6 nmol/min/mg of protein, respectively, at 200 μM 4MU concentration), indicating that placental cells may be capable of glucuronidating 4MU. The American Society for Pharmacology and Experimental Therapeutics ER -